Names | |
---|---|
IUPAC name
N1-{5-[(N-{4-[(3-aminopropyl)amino]butyl}-β-alanyl)amino]pentyl}-N2-[(2,4-dihydroxyphenyl)acetyl]-L-aspartamide
|
|
Other names
Joro Spider toxin
|
|
Identifiers | |
112163-33-4 | |
3D model (Jmol) | Interactive image |
ChEBI | CHEBI:245409 |
ChEMBL | ChEMBL119582 |
ChemSpider | 106778 |
ECHA InfoCard | 100.217.900 |
4229 | |
KEGG | C13931 |
PubChem | 119582 |
|
|
|
|
Properties | |
C27H47N7O6 | |
Molar mass | 565.72 g·mol−1 |
Appearance | White-grey powder |
Density | 1.196 g/cm3 |
Boiling point | 979.883 °C (1,795.789 °F; 1,253.033 K) |
Acidity (pKa) | 9.53 |
Basicity (pKb) | 10.573 |
Hazards | |
Flash point | 546.414 °C (1,015.545 °F; 819.564 K) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Joro spider toxin (joro toxin, JSTX) - a toxin which was originally extracted from the spider Nephila clavata venom. The compound has demonstrated the ability to selectively block postsynaptic glutamate potentials, AMPA glutamate receptors, and to antagonise the effect of NMDA receptors in the CNS of vertebrates. However, it does not affect aspartate-induced neural depolarization, resting membrane potential, nerve terminal spontaneous signalling, or inhibitory postsynaptic potentials.